Read + Share
Cheng Y, Zhou Q, Han B, Fan Y, et al. NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients
with metastatic non-small-cell lung cancer. Lung Cancer 2023;178:87-95.
PMID: 36806898
|
 |
|
Cheng Y, Zhou Q, Han B, Fan Y, et al. NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients
with metastatic non-small-cell lung cancer. Lung Cancer 2023;178:87-95.
PMID: 36806898
|
|
|
|